Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.

Name: Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Author: Jackson, Graham H

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. — المؤلف: Jackson, Graham H — The Lancet. Oncology 20200416

المؤلف: Jackson, Graham H
النشر: The Lancet. Oncology 20200416
الوصف: 57-73 p.
الموضوعات: Hematopoietic Stem Cell Transplantation؛ Humans؛ Intention to Treat Analysis؛ Lenalidomide؛ Maintenance Chemotherapy؛ Multiple Myeloma؛ Progression-Free Survival؛ Transplantation, Autologous